Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN)


Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Regeneron Pharmaceuticals (REGN) Profile

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York, about 25 miles north of Midtown Manhattan.

Number of employees 9,123 (2020) Total assets US$17.163 billion (2020) Market cap 67.26 B USD

Regeneron Pharmaceuticals (REGN.xnas))News TARRYTOWN, N.Y., Dec. 22, 2021 /PRNewswire/ Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022. The presentation is scheduled for 10:30 a.m. Eastern Time and may be accessed from the "Investors & Media" page of Regeneron's website

Subsidiaries Rockwood Road Holdings LLC, Regeneron Assurance Inc., Loop Road Holdings LLC, Regeneron Healthcare Solutions Inc.

Regeneron Pharmaceuticals (REGN.xnas))News Dec 23 (Reuters) - The U.S. government has paused the distribution of COVID-19 antibody treatments from Regeneron Pharmaceuticals REGN.O and Eli Lilly LLY.N, saying the therapies were unlikely to be effective against the Omicron coronavirus variant.The variant has become the dominant strain in the United States with lightning speed, resurrecting restrictions and stretching the country's testing infrastructure.

Regeneron Pharmaceuticals (REGN.xnas) Analysis Regeneron has leveraged its monoclonal antibody research and development platform to become one of the few biotechs to successfully emerge as a profitable commercial operation

Holding cost
Largos
-5%
Cortos
-2.5%
Trading hours in US Eastern Time
Fri
10:00 - 18:30
Mon
10:00 - 18:30
Tue
10:00 - 18:30
Wed
10:00 - 18:30
Thu
10:00 - 18:30
Sun
Cierra
Sat
Cierra

Start Trading Regeneron Pharmaceuticals (REGN)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as acciones, commodities, y foreign exchange, y índices.

6 razones para operar CFD sobre acciones con FP Markets

Regulado en Australia
Bróker de forex y CFD

A largo o a corto

Increase your ability to profit in all market conditions Leverage options up to 20:1

Ejecución DMA
(Acceso directo al mercado)

Precios de acciones transparentes
y en tiempo real Control, funcionalidad y liquidez abundante
Total profundidad de mercado
y vista de órdenes en la cola

Plataformas avanzadas
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

Soporte multilingüe 24/7

Award winning support & personal account managers

Exposición global

Márgenes bajos y comisiones competitivas en +10.000 productos en acciones globales en cuatro continentes

Gana dividendos

On long positions No ownership of physical shares necessary

Empieza a hacer trading
en cuestión de minutos.

Abre una cuenta ahora

bullet Accede a más de 10.000 instrumentos financieros
bullet Apertura y cierre automático de posiciones
bullet Noticias y agenda económica
bullet Indicadores técnicos y gráficos
bullet Muchas más herramientas incluidas

Al proporcionar su correo electrónico, usted acepta la política de privacidad de FP Markets y está de acuerdo en recibir futuros mensajes de marketing por parte de FP Markets. Puede darse de baja en cualquier momento.





Get instant Updates in Telegram
Mapa del sitio | © FP Markets 2022